Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Interactive Journal of Medical Research

Date Submitted: Nov 17, 2022
Date Accepted: May 20, 2024

The final, peer-reviewed published version of this preprint can be found here:

Predictive Value of Physiological Values and Symptom Scores for Exacerbations in Bronchiectasis and Chronic Obstructive Pulmonary Disease With Frequent Exacerbations: Longitudinal Observational Cohort Study

Jones TL, Roberts C, Elliott S, Glaysher S, Green B, Shute JK, Chauhan AJ

Predictive Value of Physiological Values and Symptom Scores for Exacerbations in Bronchiectasis and Chronic Obstructive Pulmonary Disease With Frequent Exacerbations: Longitudinal Observational Cohort Study

Interact J Med Res 2024;13:e44397

DOI: 10.2196/44397

PMID: 39378078

PMCID: 11496917

Predictive value of physiological values and symptom scores for exacerbations: a cohort study of frequent exacerbators with bronchiectasis and COPD

  • Thomas Llewelyn Jones; 
  • Claire Roberts; 
  • Scott Elliott; 
  • Sharon Glaysher; 
  • Ben Green; 
  • Janis K Shute; 
  • Anoop J Chauhan

ABSTRACT

Background:

COPD and bronchiectasis are common and exacerbations contribute to their morbidity and mortality. Predictive factors for frequency of future exacerbations include previous exacerbation frequency and airway colonisation. Earlier treatment of exacerbations is likely to reduce severity.

Objective:

To determine whether changes in physiological variables or symptom scores can predict exacerbations of chronic airway disease in participants colonised with Pseudomonas aeruginosa or Haemophilus influenzae

Methods:

We performed a longitudinal observational cohort study of 30 participants with bronchiectasis and/or COPD, at least 2 exacerbations per year and colonisation with Pseudomonas aeruginosa or Haemophilus influenzae. Daily symptom and physiological data were collected comprising pulse rate, blood pressure, oxygen saturation, peak flow rate, step count, weight and temperature. Exacerbations (defined as the onset of new antibiotics for respiratory symptoms) were collected, and predictive values for abnormal values in the ten days prior to an exacerbation were calculated.

Results:

30 participants were recruited collecting a total of 39,534 physiological and 25,334 symptom data points across 5,358 participant-days including 78 exacerbations. Peak flow rate and weight were significantly different at the point of exacerbation but no significant trends around exacerbation were noted and no clinically beneficial predictive value was found in overall or individually adjusted models. Symptom scores trended to worsening for 10 days either side of an exacerbation, but of insufficient magnitude for prediction with AUROC values of 0.4-0.6.

Conclusions:

This study demonstrated a lack of utility for either physiological or visual analogue scale symptom predictors in early detection of exacerbations in participants with frequent exacerbation and airway colonisation. This suggests that the self-management education provided as standard of care is superior to either of these other approaches.


 Citation

Please cite as:

Jones TL, Roberts C, Elliott S, Glaysher S, Green B, Shute JK, Chauhan AJ

Predictive Value of Physiological Values and Symptom Scores for Exacerbations in Bronchiectasis and Chronic Obstructive Pulmonary Disease With Frequent Exacerbations: Longitudinal Observational Cohort Study

Interact J Med Res 2024;13:e44397

DOI: 10.2196/44397

PMID: 39378078

PMCID: 11496917

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.